{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T07:08:31Z","timestamp":1778742511708,"version":"3.51.4"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2005,6,29]],"date-time":"2005-06-29T00:00:00Z","timestamp":1120003200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2005,10]]},"DOI":"10.1007\/s00213-005-0030-7","type":"journal-article","created":{"date-parts":[[2005,6,28]],"date-time":"2005-06-28T10:48:50Z","timestamp":1119955730000},"page":"58-64","source":"Crossref","is-referenced-by-count":22,"title":["Effect of repeated administrations of heroin, naltrexone, methadone, and alcohol on morphine glucuronidation in the rat"],"prefix":"10.1007","volume":"182","author":[{"given":"Letizia","family":"Antonilli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emma","family":"Petecchia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniele","family":"Caprioli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aldo","family":"Badiani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo","family":"Nencini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2005,6,29]]},"reference":[{"key":"30_CR1","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1007\/s00213-003-1531-x","volume":"170","author":"L Antonilli","year":"2003","unstructured":"Antonilli L, Semeraro F, Suriano C, Signore L, Nencini P (2003a) High levels of morphine-6-glucuronide in street heroin addicts. Psychopharmacology (Berl) 170:200\u2013204","journal-title":"Psychopharmacology (Berl)"},{"key":"30_CR2","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1124\/jpet.103.055467","volume":"307","author":"L Antonilli","year":"2003","unstructured":"Antonilli L, Suriano C, Paolone G, Badiani A, Nencini P (2003b) Repeated exposures to heroin and\/or cadmium alter the rate of formation of morphine glucuronides in the rat. J Pharmacol Exp Ther 307:651\u2013660","journal-title":"J Pharmacol Exp Ther"},{"key":"30_CR3","first-page":"53","volume":"26","author":"M Bayes","year":"2004","unstructured":"Bayes M, Rabasseda X, Prous JR (2004) Gateways to clinical trials. Methods Find Exp Clin Pharmacol 26:53\u201384","journal-title":"Methods Find Exp Clin Pharmacol"},{"key":"30_CR4","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1159\/000139030","volume":"46","author":"HN Bhargava","year":"1993","unstructured":"Bhargava HN, Rahmani NH, Villar VM, Larsen AK (1993) Effects of naltrexone on pharmacodynamics and pharmacokinetics of intravenously administered morphine in the rat. Pharmacology 46:66\u201374","journal-title":"Pharmacology"},{"key":"30_CR5","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/j.1399-6576.1997.tb04625.x","volume":"41","author":"LL Christrup","year":"1997","unstructured":"Christrup LL (1997) Morphine metabolites. Acta Anaesthesiol Scand 41:116\u2013122","journal-title":"Acta Anaesthesiol Scand"},{"key":"30_CR6","doi-asserted-by":"crossref","first-page":"267","DOI":"10.3109\/00498259309059380","volume":"23","author":"MR Franklin","year":"1993","unstructured":"Franklin MR, Slawson MH, Moody DE (1993) Selective induction of rat liver phase II enzymes by N-heterocycle analogues of phenanthrene: a response exhibiting high correlation between UDP-glucuronosyltransferase and microsomal epoxide hydrolase activities. Xenobiotica 23:267\u2013277","journal-title":"Xenobiotica"},{"key":"30_CR7","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1046\/j.1360-0443.2003.00330.x","volume":"98","author":"A Fugelstad","year":"2003","unstructured":"Fugelstad A, Ahlner J, Brandt L, Ceder G, Eksborg S, Rajs J, Beck O (2003) Use of morphine and 6-monoacetylmorphine in blood for the evaluation of possible risk factors for sudden death in 192 heroin users. Addiction 98:463\u2013470","journal-title":"Addiction"},{"key":"30_CR8","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1520\/JFS14420J","volume":"44","author":"F Infante","year":"1999","unstructured":"Infante F, Dominguez E, Trujillo D, Luna A (1999) Metal contamination in illicit samples of heroin. J Forensic Sci 44:110\u2013113","journal-title":"J Forensic Sci"},{"key":"30_CR9","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1007\/s002280050003","volume":"55","author":"P Klepstad","year":"2000","unstructured":"Klepstad P, Kaasa S, Borchgrevink PC (2000) Start of oral morphine to cancer patients: effective serum morphine concentrations and contribution from morphine-6-glucuronide to the analgesia produced by morphine. Eur J Clin Pharmacol 55:713\u2013719","journal-title":"Eur J Clin Pharmacol"},{"key":"30_CR10","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s002280050412","volume":"54","author":"U Klotz","year":"1998","unstructured":"Klotz U, Ammon E (1998) Clinical and toxicological consequences of the inductive potential of ethanol. Eur J Clin Pharmacol 54:7\u201312","journal-title":"Eur J Clin Pharmacol"},{"key":"30_CR11","doi-asserted-by":"crossref","first-page":"485","DOI":"10.2165\/00003088-200140070-00001","volume":"40","author":"J Lotsch","year":"2001","unstructured":"Lotsch J, Geisslinger G (2001) Morphine-6-glucuronide: an analgesic of the future? Clin Pharmacokinet 40:485\u2013499","journal-title":"Clin Pharmacokinet"},{"key":"30_CR12","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1097\/00000542-200210000-00011","volume":"97","author":"J Lotsch","year":"2002","unstructured":"Lotsch J, Zimmermann M, Darimont J, Marx C, Dudziak R, Skarke C, Geisslinger G (2002) Does the A118G polymorphism at the mu-opioid receptor gene protect against morphine-6-glucuronide toxicity? Anesthesiology 97:814\u2013819","journal-title":"Anesthesiology"},{"key":"30_CR13","first-page":"592","volume":"54","author":"I Meineke","year":"2002","unstructured":"Meineke I, Freudenthaler S, Hofmann U, Schaeffeler E, Mikus G, Schwab M, Prange HW, Gleiter CH, Brockmoller J (2002) Pharmacokinetic modelling of morphine, morphine-3-glucuronide and morphine-6-glucuronide in plasma and cerebrospinal fluid of neurosurgical patients after short-term infusion of morphine. Br J Clin Pharmacol 54:592\u2013603","journal-title":"Br J Clin Pharmacol"},{"key":"30_CR14","doi-asserted-by":"crossref","first-page":"345","DOI":"10.3109\/03602539608994011","volume":"28","author":"RW Milne","year":"1996","unstructured":"Milne RW, Nation RL, Somogyi AA (1996) The disposition of morphine and its 3 and 6-glucuronide metabolites in humans and animals, and the importance of the metabolites to the pharmacological effects of morphine. Drug Metab Rev 28:345\u2013472","journal-title":"Drug Metab Rev"},{"key":"30_CR15","doi-asserted-by":"crossref","first-page":"515","DOI":"10.3109\/00498259109039491","volume":"21","author":"SS Narayan","year":"1991","unstructured":"Narayan SS, Hayton WL, Yost GS (1991) Chronic ethanol consumption causes increased glucuronidation of morphine in rabbits. Xenobiotica 21:515\u2013524","journal-title":"Xenobiotica"},{"key":"30_CR16","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1093\/ndt\/14.4.903","volume":"14","author":"C Pauli-Magnus","year":"1999","unstructured":"Pauli-Magnus C, Hofmann U, Mikus G, Kuhlmann U, Mettang T (1999) Pharmacokinetics of morphine and its glucuronides following intravenous administration of morphine in patients undergoing continuous ambulatory peritoneal dialysis. Nephrol Dial Transplant 14:903\u2013909","journal-title":"Nephrol Dial Transplant"},{"key":"30_CR17","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1067\/mcp.2000.111934","volume":"68","author":"RT Penson","year":"2000","unstructured":"Penson RT, Joel SP, Bakhshi K, Clark SJ, Langford RM, Slevin ML (2000) Randomized placebo-controlled trial of the activity of the morphine glucuronides. Clin Pharmacol Ther 68:667\u2013676","journal-title":"Clin Pharmacol Ther"},{"key":"30_CR18","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/BF00265969","volume":"38","author":"GM Peterson","year":"1990","unstructured":"Peterson GM, Randall CT, Paterson J (1990) Plasma levels of morphine and morphine glucuronides in the treatment of cancer pain: relationship to renal function and route of administration. Eur J Clin Pharmacol 38:121\u2013124","journal-title":"Eur J Clin Pharmacol"},{"key":"30_CR19","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1097\/00000542-200401000-00021","volume":"100","author":"R Romberg","year":"2004","unstructured":"Romberg R, Olofsen E, Sarton E, den Hartigh J, Taschner PE, Dahan A (2004) Pharmacokinetic-pharmacodynamic modeling of morphine-6-glucuronide-induced analgesia in healthy volunteers: absence of sex differences. Anesthesiology 100:120\u2013133","journal-title":"Anesthesiology"},{"key":"30_CR20","first-page":"619","volume":"5","author":"EL Schwartz","year":"1992","unstructured":"Schwartz EL, Brechbuhl AB, Kahl P, Miller MA, Selwyn PA, Friedland GH (1992) Pharmacokinetic interactions of zidovudine and methadone in intravenous drug-using patients with HIV infection. J Acquir Immune Defic Syndr 5:619\u2013626","journal-title":"J Acquir Immune Defic Syndr"},{"key":"30_CR21","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1067\/mcp.2003.5","volume":"73","author":"C Skarke","year":"2003","unstructured":"Skarke C, Darimont J, Schmidt H, Geisslinger G, Lotsch J (2003) Analgesic effects of morphine and morphine-6-glucuronide in a transcutaneous electrical pain model in healthy volunteers. Clin Pharmacol Ther 73:107\u2013121","journal-title":"Clin Pharmacol Ther"},{"key":"30_CR22","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1128\/AAC.42.7.1592","volume":"42","author":"CB Trapnell","year":"1998","unstructured":"Trapnell CB, Klecker RW, Jamis-Dow C, Collins JM (1998) Glucuronidation of 3\u2032-azido-3\u2032-deoxythymidine (zidovudine) by human liver microsomes: relevance to clinical pharmacokinetic interactions with atovaquone, fluconazole, methadone, and valproic acid. Antimicrob Agents Chemother 42:1592\u20131596","journal-title":"Antimicrob Agents Chemother"},{"key":"30_CR23","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1016\/S0006-2952(01)00761-4","volume":"62","author":"C Ulens","year":"2001","unstructured":"Ulens C, Baker L, Ratka A, Waumans D, Tytgat J (2001) Morphine-6beta-glucuronide and morphine-3-glucuronide, opioid receptor agonists with different potencies. Biochem Pharmacol 62:1273\u20131282","journal-title":"Biochem Pharmacol"},{"key":"30_CR24","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1097\/00007691-200310000-00015","volume":"25","author":"M Euler von","year":"2003","unstructured":"von Euler M, Villen T, Svensson JO, Stahle L (2003) Interpretation of the presence of 6-monoacetylmorphine in the absence of morphine-3-glucuronide in urine samples: evidence of heroin abuse. Ther Drug Monit 25:645\u2013648","journal-title":"Ther Drug Monit"},{"key":"30_CR25","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/0378-4347(93)80304-M","volume":"615","author":"D Wielbo","year":"1993","unstructured":"Wielbo D, Bhat R, Chari G, Vidyasagar D, Tebbett IR, Gulati A (1993) High-performance liquid chromatographic determination of morphine and its metabolites in plasma using diode-array detection. J Chromatogr 615:164\u2013168","journal-title":"J Chromatogr"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-005-0030-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00213-005-0030-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-005-0030-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T16:31:03Z","timestamp":1558629063000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00213-005-0030-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,6,29]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,10]]}},"alternative-id":["30"],"URL":"https:\/\/doi.org\/10.1007\/s00213-005-0030-7","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,6,29]]}}}